期刊文献+
共找到2,237篇文章
< 1 2 112 >
每页显示 20 50 100
Effect of Sishen pill on expression of type Ⅰ and type Ⅲ interferon in acute ulcerative colitis mice model
1
作者 Jia-Min Dong Tao Lu +4 位作者 Ke Li Meng-Jia Li Xu-Dan Wang Dong-Yu Ge Ying Wu 《Journal of Hainan Medical University》 2022年第11期1-6,共6页
Objective:To investigate the effects of Sishen pill on the expression of type I interferon(IFN)and type III interferon and their receptors in colonic tissues of mice with acute ulcerative colitis(UC).Methods:Male C57B... Objective:To investigate the effects of Sishen pill on the expression of type I interferon(IFN)and type III interferon and their receptors in colonic tissues of mice with acute ulcerative colitis(UC).Methods:Male C57BL/6Cnc mice were randomly divided into control group,model group,sishenwan group and salazosulfapyridine group.The model was made with 0.2 mL 4%dextran sodium sulfate(DSS)for 5 days,and the control group was given 0.2mL normal saline by gavage.On the second day of modeling,sishen pill group was given 0.2mL 1.5 g·kg^(-1) sishen pill,and SASP group was given 0.2mL 0.25 g·kg^(-1) sulfasalazine,twice a day,for 7 days.During the administration period,the disease activity index(DAI)of mice was calculated every day.After administration,the histopathological changes of colon tissues of mice in each group were observed by hematoxylin eosin(HE)staining,and the histological scores were calculated.The expression of IFN-α,IFN-β,IFN-λ2 and IFN-λ3 mRNAs in colon tissues of mice in each group were detected by qRT-PCR.The expression levels of IFN-α,IFN-β,IFN-λ2 and IFN-λ3 in colon tissues of mice in each group were detected by ELISA.Western blot was used to detect the expression of interferon receptors IFNAR1,IFNAR2 and IFNLR1 in colon tissues of mice in each group.Results:Compared with the control group,the DAI of mice increased significantly(P<0.001)in the model group.The inflammatory cells in colonic tissues infiltrated heavily,lymph nodes enlarged,colonic mucosal structure destroyed,crypt structure lost,inflammation involved a wide range,and the histological score increased significantly(P<0.001).The levels of IFN-α,IFN-βand IFNλ2 mRNA were significantly decreased(P<0.05,P<0.05,P<0.01).The expression levels of IFN-α,IFN-β,IFN-λ2 and IFN-λ3 were significantly decreased(P<0.01,P<0.01,P<0.001,P<0.001).The levels of IFNAR1,IFNAR2 and IFNLR1 were significantly decreased(P<0.01,P<0.05,P<0.01).Compared with the model group,the DAI decreased significantly(P<0.001)in Sishen pill group,the infiltration of inflammatory cells in colon tissue were significantly reduced,the structural regeneration of colon mucosa was significantly recovered,the crypt structure was significantly recovered,the lymph nodes were significantly reduced,the range of inflammation involvement was reduced,and the histological score was significantly reduced(P<0.001).The levels of IFN-α,IFN-βand IFN-λ2 mRNA were significantly increased(P<0.01,P<0.001,P<0.001).The levels of IFN-α,IFN-β,IFN-λ2 and IFN-λ3 were significantly increased(P<0.01,P<0.001,P<0.01,P<0.001).The levels of IFNAR1,IFNAR2 and IFNLR1 were significantly increased(P<0.05,P<0.001,P<0.05).Conclusion:Sishen pill may alleviate the symptoms and signs of mice with acute ulcerative colitis by regulating the expression of type I and type III interferon and their receptors in colon tissues. 展开更多
关键词 typeinterferon typeinterferon Ulcerative colitis Sishen pill
下载PDF
“Hepatic hilum area priority,liver posterior first”:An optimized strategy in laparoscopic resection for type Ⅲ-Ⅳ hilar cholangiocarcinoma
2
作者 Xiao-Si Hu Yong Wang +6 位作者 Hong-Tao Pan Chao Zhu Shi-Lei Chen Shuai Zhou Hui-Chun Liu Qing Pang Hao Jin 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第7期2167-2174,共8页
BACKGROUND In recent years,pure laparoscopic radical surgery for Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma(HCCA)has been preliminarily explored and applied,but the surgical strategy and safety are still... BACKGROUND In recent years,pure laparoscopic radical surgery for Bismuth-Corlette type Ⅲ and Ⅳ hilar cholangiocarcinoma(HCCA)has been preliminarily explored and applied,but the surgical strategy and safety are still worthy of further improvement and attention.AIM To summarize and share the application experience of the emerging strategy of“hepatic hilum area dissection priority,liver posterior separation first”in pure laparoscopic radical resection for patients with HCCA of Bismuth-Corlette types Ⅲ and IV.METHODS The clinical data and surgical videos of 6 patients with HCCA of Bismuth-Corlette types Ⅲ and Ⅳ who underwent pure laparoscopic radical resection in our department from December 2021 to December 2023 were retrospectively analyzed.RESULTS Among the 6 patients,4 were males and 2 were females.The average age was 62.2±11.0 years,and the median body mass index was 20.7(19.2-24.1)kg/m^(2).The preoperative median total bilirubin was 57.7(16.0-155.7)μmol/L.One patient had Bismuth-Corlette type Ⅲa,4 patients had Bismuth-Corlette type Ⅲb,and 1 patient had Bismuth-Corlette type Ⅳ.All patients successfully underwent pure laparoscopic radical resection following the strategy of“hepatic hilum area dissection priority,liver posterior separation first”.The operation time was 358.3±85.0 minutes,and the intraoperative blood loss volume was 195.0±108.4 mL.None of the patients received blood transfusions during the perioperative period.The median length of stay was 8.3(7.0-10.0)days.Mild bile leakage occurred in 2 patients,and all patients were discharged without serious surgery-related complications.CONCLUSION The emerging strategy of“hepatic hilum area dissection priority,liver posterior separation first”is safe and feasible in pure laparoscopic radical surgery for patients with HCCA of Bismuth-Corlette types Ⅲ and Ⅳ.This strategy is helpful for promoting the modularization and process of pure laparoscopic radical surgery for complicated HCCA,shortens the learning curve,and is worthy of further clinical application. 展开更多
关键词 Hilar cholangiocarcinoma Bismuth-Corlette typesandⅣ LAPAROSCOPY Radical resection Strategy
下载PDF
微针导入重组Ⅲ型人源化胶原蛋白在皮肤屏障功能修复中的应用效果 被引量:1
3
作者 于文渊 耿栋芸 +3 位作者 庄卉如 陆蒋惠文 邱丹丹 赵天兰 《临床医学研究与实践》 2024年第7期102-105,共4页
目的探究微针导入重组Ⅲ型人源化胶原蛋白治疗因皮肤炎性衰老导致的皮肤屏障功能下降的有效性及安全性。方法选取2020年6月至2021年5月在本院接受面部皮肤治疗的30例患者作为研究对象,采用随机数字表法将其分为对照组(重组Ⅲ型人源化胶... 目的探究微针导入重组Ⅲ型人源化胶原蛋白治疗因皮肤炎性衰老导致的皮肤屏障功能下降的有效性及安全性。方法选取2020年6月至2021年5月在本院接受面部皮肤治疗的30例患者作为研究对象,采用随机数字表法将其分为对照组(重组Ⅲ型人源化胶原蛋白)与治疗组(微针导入重组Ⅲ型人源化胶原蛋白),各15例。治疗后定期对患者进行随访,分别进行主观疗效评价及客观疗效评价。结果治疗后4、8、12周,治疗组的满意度显著高于对照组(P<0.05)。治疗后,治疗组的皮肤皱纹、纹理、红区、毛孔、弹性、皮肤经皮失水及皮肤含水量改善明显(P<0.05);对照组治疗后油脂改善明显(P<0.05)。治疗后12周,治疗组的总症状评分显著低于对照组(P<0.05)。结论微针导入重组Ⅲ型人源化胶原蛋白对皮肤修复有较好的疗效,可增强皮肤屏障功能,为改善皮肤屏障功能、治疗因皮肤屏障受损引起的炎性衰老提供了新选择。 展开更多
关键词 微针 重组型人源化胶原蛋白 炎性衰老 皮肤屏障功能
下载PDF
柴归颗粒对水瘀互结型Ⅲ型前列腺炎患者的影响
4
作者 李刚琴 蒋霖 +1 位作者 白宽 谭广兴 《云南中医药大学学报》 2024年第3期8-12,共5页
目的观察柴归颗粒治疗Ⅲ型前列腺炎水瘀互结证患者的临床疗效及对前列腺液细胞因子等指标的影响。方法将水瘀互结型Ⅲ型前列腺炎患者随机分为治疗组(35例)与对照组(27例)。对照组予盐酸坦索罗辛缓释胶囊口服,治疗组予柴归颗粒口服。比较... 目的观察柴归颗粒治疗Ⅲ型前列腺炎水瘀互结证患者的临床疗效及对前列腺液细胞因子等指标的影响。方法将水瘀互结型Ⅲ型前列腺炎患者随机分为治疗组(35例)与对照组(27例)。对照组予盐酸坦索罗辛缓释胶囊口服,治疗组予柴归颗粒口服。比较2组患者治疗前后慢性前列腺炎症状指数(NIH-CPSI)评分、前列腺液细胞因子变化情况及临床疗效。结果治疗组在接受治疗后,其NIH-CPSI评分明显降低,与治疗前相比存在显著差异(P<0.05)。此外,与对照组相比治疗组治疗后的NIH-CPSI评分明显降低(P<0.05)。在对照组中,治疗后的IL-2水平与该组治疗前相比存在统计学意义的差异(P<0.05)。治疗后,治疗组的IL-2、IL-6、IL-8水平显著降低(P<0.05),且与对照组相比,IL-2、IL-6水平更低(P<0.05)。治疗组的中医证候总有效率明显高于对照组(P<0.05)。结论柴归颗粒能明显改善Ⅲ型前列腺炎水瘀互结证患者临床症状,提高临床疗效,其机制可能与调节前列腺液细胞因子水平有关,值得进一步研究。 展开更多
关键词 柴归颗粒 型前列腺炎 水瘀互结证 前列腺液 细胞因子
下载PDF
The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson's disease
5
作者 Shengyang Zhou Ting Li +8 位作者 Wei Zhang Jian Wu Hui Hong Wei Quan Xinyu Qiao Chun Cui Chenmeng Qiao Weijiang Zhao Yanqin Shen 《Neural Regeneration Research》 SCIE CAS 2025年第8期2361-2372,共12页
Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report... Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report that interferon regulatory factor 7 is markedly up-regulated in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease and co-localizes with microglial cells.Both the selective cyclic guanosine monophosphate adenosine monophosphate synthase inhibitor RU.521 and the stimulator of interferon genes inhibitor H151 effectively suppressed interferon regulatory factor 7 activation in BV2 microglia exposed to 1-methyl-4-phenylpyridinium and inhibited transformation of mouse BV2 microglia into the neurotoxic M1 phenotype.In addition,si RNA-mediated knockdown of interferon regulatory factor 7 expression in BV2 microglia reduced the expression of inducible nitric oxide synthase,tumor necrosis factorα,CD16,CD32,and CD86 and increased the expression of the anti-inflammatory markers ARG1 and YM1.Taken together,our findings indicate that the cyclic guanosine monophosphate adenosine monophosphate synthase-stimulator of interferon genes-interferon regulatory factor 7 pathway plays a crucial role in the pathogenesis of Parkinson's disease. 展开更多
关键词 cyclic guanosine monophosphate adenosine monophosphate synthase H151 interferon regulatory factor 7 M1 phenotype neurodegenerative disease NEUROINFLAMMATION Parkinson’s disease RU521 STING type I interferon
下载PDF
少腹逐瘀汤联合针刺对Ⅲ型前列腺炎疼痛症患者的治疗效果及对患者生活质量的影响
6
作者 彭博 王琳 《四川中医》 2024年第5期125-128,共4页
目的:探讨少腹逐瘀汤联合针刺对Ⅲ型前列腺炎疼痛症患者的治疗效果及对患者生活质量的影响。方法:选取2021年4月~2023年3月于武汉大学中南医院接受诊治的122例符合标准的Ⅲ型前列腺炎患者为研究对象,随机分为两组,对照组(n=61)与观察组(... 目的:探讨少腹逐瘀汤联合针刺对Ⅲ型前列腺炎疼痛症患者的治疗效果及对患者生活质量的影响。方法:选取2021年4月~2023年3月于武汉大学中南医院接受诊治的122例符合标准的Ⅲ型前列腺炎患者为研究对象,随机分为两组,对照组(n=61)与观察组(n=61)。对照组接受盐酸坦索罗辛缓释胶囊加针刺治疗,观察组在对照组基础上加少腹逐瘀汤治疗,疗程为4周。比较两组疼痛、生活质量、相关炎症指标及临床有效率、不良反应发生率。结果:观察组临床总有效率显著高于对照组(P<0.05);治疗前两组患者慢性前列腺炎症状积分指数(NIH-CPSI)评分、中医症候积分及前列腺液白细胞(WBC)、卵磷脂小体(SPL)计数、白细胞介素(IL-6)水平均无显著差异(P>0.05),治疗后观察组NIH-CPSI评分、中医症候积分及WBC计数、IL-6水平均显著低于对照组,观察组SPL计数低于对照组(P<0.05);两组不良反应发生率差异无统计学意义(P>0.05)。结论:少腹逐瘀汤联合针刺治疗Ⅲ型前列腺炎可有效提高疗效,降低疼痛与不适程度、改善排尿症状,以改善患者生活质量,调节炎症指标,同时无不良反应增加,具有良好的推广价值。 展开更多
关键词 少腹逐瘀汤 针刺 型前列腺炎 生活质量 临床疗效
下载PDF
成人骨型Ⅲ类矫治前后前牙区变化的临床研究
7
作者 何方林 蒋立辉 +1 位作者 宋思吟 吴萍 《中国卫生标准管理》 2024年第9期106-109,共4页
目的探讨成人骨型Ⅲ类患者矫治前后上下前牙区牙槽高度和宽度变化以及前牙区牙根位置变化。方法选取2020年5月—2022年11月在中山市小榄人民医院口腔科正畸掩饰治疗的成人骨型Ⅲ类患者50例,比较正畸治疗前后患者上下颌前牙牙槽骨厚度和... 目的探讨成人骨型Ⅲ类患者矫治前后上下前牙区牙槽高度和宽度变化以及前牙区牙根位置变化。方法选取2020年5月—2022年11月在中山市小榄人民医院口腔科正畸掩饰治疗的成人骨型Ⅲ类患者50例,比较正畸治疗前后患者上下颌前牙牙槽骨厚度和高度,其中包括上前牙槽骨厚度(upper anterior alveolar bonethickness,UA)、上后牙槽骨厚度(upper posterior alveolar bone thickness,UP)、上牙槽骨总厚度(upper alveolar bone width,UW)、下前牙槽骨厚度(lower anterior alveolar bone thickness,LA)、下后牙槽骨厚度(lower posterior alveolar bone thickness,LP)、下牙槽骨总厚度(lower alveolar bone width,LW)、根中水平上前牙槽骨厚度(upper anterior alveolar bone thickness at the mid-root level,UA-m)、根中水平上后牙槽骨厚度(upper posterior alveolar bone thickness at the mid-root level,UP-m)、根中水平上牙槽骨总厚度(upper alveolar bone thickness at the mid-root level,UW-m)、根中水平下前牙槽骨厚度(lower anterior alveolar bone thickness at the mid-root level,LA-m)、根中水平下后牙槽骨厚度(lower posterior alveolar bone thickness at the mid-root level,LP-m)、根中水平下牙槽骨总厚度(lower alveolar bone thickness at the mid-root level,LW-m)以及上前牙槽骨高度(upper anterior alveolar bone height,UAH)和下前牙槽骨高度(lower anterior alveolarbone height,LAH)。结果正畸治疗前后患者UA、UP-m测量值比较,差异无统计学意义(P>0.05)。与正畸治疗前比较,正畸治疗后患者UP、UW、UA-m、UW-m测量值均显著降低(P<0.05)。正畸治疗后患者LP、LA-m测量值与正畸治疗前比较,差异无统计学意义(P>0.05)。与正畸治疗前比较,正畸治疗后患者LA、LW、LP-m、LW-m测量值均降低(P<0.05)。与正畸治疗前比较,正畸治疗后患者UAH、LAH测量值均显著降低(P<0.05)。正畸治疗后,患者上下颌前牙解剖牙根长度分别为(10.62±0.57)mm、(9.65±0.48)mm,正畸治疗前患者上下颌前牙解剖牙根长度分别为(11.01±0.58)mm、(10.37±0.48)mm,与正畸治疗前比较,患者上下颌前牙解剖牙根长度明显减小(P<0.05)。结论成人骨型Ⅲ类患者进行正畸掩饰治疗后,牙槽形态会发生相应改变,患者上下前牙牙槽骨厚度和高度会一定程度地减少。因此,在矫治过程中应当对患者牙槽形态的变化给予密切关注,尽量避免上下前牙发生代偿性移动,从而降低不良反应情况发生的风险。 展开更多
关键词 成人骨型 正畸掩饰治疗 前牙区 牙槽形态 牙槽高度 牙槽宽度 代偿性移动
下载PDF
羟基酸与Ⅲ型胶原蛋白的护肤功效研究
8
作者 运薪如 陆杨燕 张国栋 《云南化工》 CAS 2024年第9期61-64,共4页
旨在研究验证羟基酸和重组Ⅲ型胶原蛋白对皮肤水分及屏障的影响。招募志愿者共12人,使用多功能皮肤测试仪测量了受试者连续使用含羟基酸和Ⅲ型胶原蛋白护肤品时皮肤水分含量、经皮失水量的变化。结果表明复合酸类产品具有保湿补水、修... 旨在研究验证羟基酸和重组Ⅲ型胶原蛋白对皮肤水分及屏障的影响。招募志愿者共12人,使用多功能皮肤测试仪测量了受试者连续使用含羟基酸和Ⅲ型胶原蛋白护肤品时皮肤水分含量、经皮失水量的变化。结果表明复合酸类产品具有保湿补水、修复屏障的功效,且其补水效果与酸种类有关。证明了重组Ⅲ型胶原蛋白对于促进皮肤水含量提升及经皮失水量降低有显著效果,且当水杨酸与Ⅲ型胶原搭配时会发挥协同作用,可以进一步强韧屏障,实现皮肤水含量的大幅度提升。 展开更多
关键词 羟基酸 型胶原蛋白 护肤 协同作用
下载PDF
上颌前方牵引联合螺旋扩弓器对替牙期骨性Ⅲ类错[牙合]颌面软硬组织的影响
9
作者 岳梦娅 刘涛 《临床研究》 2024年第3期78-81,共4页
目的在上颌前方牵引的基础上给予骨性Ⅲ类错[牙合](替牙期)患儿螺旋扩弓器进行扩缩处理治疗,观察疗效以及对患儿牙颌面软硬组织的影响。方法按随机数表法将2021年1月至2022年12月信阳市中心医院诊治的60例替牙期骨性Ⅲ类错[牙合]患儿分... 目的在上颌前方牵引的基础上给予骨性Ⅲ类错[牙合](替牙期)患儿螺旋扩弓器进行扩缩处理治疗,观察疗效以及对患儿牙颌面软硬组织的影响。方法按随机数表法将2021年1月至2022年12月信阳市中心医院诊治的60例替牙期骨性Ⅲ类错[牙合]患儿分两组。对照组30例采用上颌前方牵引治疗,联合组30例在上颌前方牵引的基础上给予螺旋扩弓器治疗,评估两组临床疗效,对比两组治疗前后颌面结构、上气道间隙及三维指标。结果联合组临床有效率(86.67%)较对照组(63.33%)更高,差异有统计学意义(P<0.05)。联合组治疗后颌面结构相关指标上下颌突差(ANB)、下颌平面角(FH-MP)、下面高(ANS-Me)、腭平面角(SN-PP)较对照组更高,上中切牙的突度(L1-MP)较对照组更低,差异有统计学意义(P<0.05)。联合组治疗后上气道间隙指标鼻咽直径(PNS-R)较对照组更高,差异有统计学意义(P<0.05)。联合组治疗后上气道三维指标鼻咽段最小截面积(NP area)、鼻咽段最小截面积处冠状径(NP cor.)、鼻咽段最小截面积位置矢状径(NP sag.)、鼻咽段容积(NP volume)较对照组更高,差异有统计学意义(P<0.05)。结论上颌前方牵引联合螺旋扩弓器疗效确切,可有效促进替牙期骨性Ⅲ类错[牙合]患儿颌面结构及上气道状态恢复,改善颌面软硬组织状态。 展开更多
关键词 软硬组织 骨性类错[牙合] 螺旋扩弓器 上颌前方牵引 替牙期
下载PDF
基于上皮细胞-间充质细胞转分化(EMT)理论的艾灸配合化纤Ⅳ号方对实验大鼠Collagen Type Ⅲ和PDGF干预作用实验研究 被引量:2
10
作者 李戎 彭彩钰 +2 位作者 赵荣光 刘涛 常全颖 《辽宁中医杂志》 CAS 北大核心 2016年第2期421-424,I0005,共5页
目的:基于上皮细胞-间充质细胞转分化(EMT)学说观察化纤Ⅳ号方、艾灸以及二者相配合治疗肺纤维化大鼠Collagen TypeⅢ(Ⅲ-C)和PDGF的变化,探讨其治疗效应及生物学机制。方法:将鼠龄约为6周的SD大鼠随机分为空白组、模型组、化纤Ⅳ号方... 目的:基于上皮细胞-间充质细胞转分化(EMT)学说观察化纤Ⅳ号方、艾灸以及二者相配合治疗肺纤维化大鼠Collagen TypeⅢ(Ⅲ-C)和PDGF的变化,探讨其治疗效应及生物学机制。方法:将鼠龄约为6周的SD大鼠随机分为空白组、模型组、化纤Ⅳ号方组、艾灸组、化纤Ⅳ号方与艾灸配合治疗组(简称为"灸药组"),治疗30 d后处死观察其肺组织病理改变,并检测其Collagen TypeⅢ、PDGF的基因和蛋白表达情况。结果:实时荧光定量结果显示:与空白组相比,各组Ⅲ-C和PDGF m RNA表达增高(P<0.05)。与模型组相比,各组的Ⅲ-C和PDGF m RNA表达有明显降低(P<0.01)。而各组中,灸药组疗效最明显,Ⅲ-C和PDGF的表达最低。蛋白免疫印迹法检测结果显示:与模型组相比各组的Ⅲ-C蛋白表达有差异。结论:1艾灸、化纤Ⅳ号方均可减轻博莱霉素诱导肺纤维化大鼠的肺纤维化程度。2艾灸配合化纤Ⅳ号方可减轻博莱霉素诱导肺纤维化大鼠的肺纤维化程度,且其效果优于单用艾灸或单用化纤Ⅳ号方。3艾灸、化纤Ⅳ号方及其二者配合使用不同程度阻抑博莱霉素诱导肺纤维化大鼠肺纤维化进程的效应机制,可能与通过调控其EMT过程中的Ⅲ-C和PDGF表达环节紧密相关。 展开更多
关键词 EMT 肺纤维化 艾灸 化纤Ⅳ号方 COLLAGEN type PDGF
下载PDF
经跗骨窦切口与外侧L形切口钢板内固定治疗SandersⅡ、Ⅲ型跟骨骨折的疗效分析 被引量:7
11
作者 余俊 胡磊 +2 位作者 周骏武 丁伟 李杰 《临床和实验医学杂志》 2023年第4期393-396,共4页
目的分析SandersⅡ、Ⅲ型跟骨骨折患者采用经跗骨窦切口与跟骨外侧L形切口钢板内固定治疗的临床疗效。方法回顾性选取2017年9月至2021年3月池州市人民医院收治的62例SandersⅡ、Ⅲ型跟骨骨折患者,按照手术方式不同分为对照组和观察组,每... 目的分析SandersⅡ、Ⅲ型跟骨骨折患者采用经跗骨窦切口与跟骨外侧L形切口钢板内固定治疗的临床疗效。方法回顾性选取2017年9月至2021年3月池州市人民医院收治的62例SandersⅡ、Ⅲ型跟骨骨折患者,按照手术方式不同分为对照组和观察组,每组31例。其中,观察组采用经跗骨窦切口复位微型钢板内固定手术治疗,对照组采用跟骨外侧L形切口钢板内固定手术治疗。对比分析两组患者的手术相关指标、术后12个月跟骨Bohler角、Gissane角以及Marland足部功能评分,并比较术后并发症发生情况。结果62例患者均接受术后随访,随访时间13~16个月。术后6个月所有患者骨折均愈合,平均骨折愈合时间3~6个月。观察组患者的手术时间、手术切口分别为(53.1±10.3)min、(4.3±0.9)cm,明显短于对照组[(84.0±15.3)min、(11.1±1.2)cm],术后疼痛评分为(1.8±0.5)分,明显低于对照组[(3.2±1.1)分],差异均有统计学意义(P<0.05)。两组患者术后12个月Bohler角、Gissane角、Maryland足部功能评分比较,差异均无统计学意义(P>0.05)。观察组患者并发症发生率为6.45%,明显低于对照组(22.58%),差异有统计学意义(P<0.05)。结论经跗骨窦切口复位微型钢板内固定手术对SandersⅡ、Ⅲ型跟骨骨折患者造成的创伤较小,骨折复位及内固定强度效果明显,术后并发症发生率降低,足部功能恢复较快。 展开更多
关键词 SandersⅡ、型跟骨骨折 内固定 经跗骨窦切口 外侧L形切口 骨折复位
下载PDF
电压模式Buck电路中Type Ⅲ型环路补偿优化方法 被引量:3
12
作者 洪怡雯 陈伯文 +1 位作者 王强 汤苏雷 《电源技术》 CAS 北大核心 2021年第9期1209-1212,1226,共5页
设计了以UP1542为电源转换芯片的电压模式Buck电路,提出了一种基于Type Ⅲ型环路补偿中零极点理论的优化方法,引入无补偿时电压模式Buck电路与传统电压模式Buck电路Type Ⅲ型环路补偿方法进行比较。试验测试结果表明:所提优化方法与Buc... 设计了以UP1542为电源转换芯片的电压模式Buck电路,提出了一种基于Type Ⅲ型环路补偿中零极点理论的优化方法,引入无补偿时电压模式Buck电路与传统电压模式Buck电路Type Ⅲ型环路补偿方法进行比较。试验测试结果表明:所提优化方法与Buck电路无补偿方法和传统电压模式Buck电路Type Ⅲ环路补偿理论设计方法相比,输出电压超调分别下降33.6%和14.9%,动态响应速度分别提升72.6%和24%,同时保证了品质因素Q附近频率的电路稳定性。该优化方法降低了动态响应误差,同时有效地减小了输出电压动态响应时间,达到了提高电路稳定性的目的,验证了该优化方法的有效性。 展开更多
关键词 电压模式 BUCK 超调 type 环路补偿 稳定性
下载PDF
Interferon therapy in hepatitis Cleading to chronic type 1 diabetes 被引量:18
13
作者 Taiba Zornitzki Stephen Malnick +1 位作者 Lyudmila Lysyy Hilla Knobler 《World Journal of Gastroenterology》 SCIE CAS 2015年第1期233-239,共7页
AIM: To review the prevalence,clinical data and course of interferon-associated type 1 diabetes in chronic hepatitis C virus(HCV) infection.METHODS: Search of all interferon(INF)-related type 1diabetes mellitus(T1DM) ... AIM: To review the prevalence,clinical data and course of interferon-associated type 1 diabetes in chronic hepatitis C virus(HCV) infection.METHODS: Search of all interferon(INF)-related type 1diabetes mellitus(T1DM) cases published in the English literature from 1992 to December 2013 according to the key words: chronic hepatitis C infection,diabetes mellitus type 1,insulin dependent diabetes mellitus,and interferon treatment.We found 107 cases and analyzed their clinical and laboratory data and long-term followup.Due to the predominance of cases described in Japanese literature,we analyzed separately cases of Caucasian and Japanese origin.In addition we describe a representative case with HCV who developed INFrelated T1 DM.RESULTS: Our data show that INF treatment increases the risk of developing T1 DM by 10-18 fold compared with the corresponding general population and the median age of onset was 43 years(range: 24-66 years) in Caucasians and 52 years(range: 45-63 years) in Japanese.Most patients developed T1 DM during INF treatment,after a median time-period of 4.2 and 5.7 mo in Caucasian and Japanese groups,respectively.The clinical course was characterized by a fulminant course with abrupt severe hyperglycemia or ketoacidosis,a high titer of anti-islet autoantibodies and almost all patients(105/107) permanently required insulin therapy with a follow-up of up to 4 years.A substantial number of patients had evidence for other autoimmune disorders mainly thyroid diseases(25% and 31% in Caucasian and Japanese groups,respectively).CONCLUSION: INF-associated T1 DM in HCV has a fulminant course,often associated with other autoimmune diseases,and results almost inevitably in permanent insulin therapy requirement. 展开更多
关键词 interferon HEPATITIS C type 1 DIABETES AUTOIMMUNE
下载PDF
硬膜外磨除前床突在Al-Mefty分型Ⅲ型前床突脑膜瘤翼点入路手术中的应用
14
作者 王序 许红旗 梁洪磊 《中国临床神经外科杂志》 2023年第8期487-489,共3页
目的探讨硬膜外前床突旁磨除在Al-Mefty分型Ⅲ型前床突脑膜瘤(ACM)翼点入路手术中应用价值。方法回顾性分析2011年12月至2021年3月经翼点入路显微手术治疗21例Al-Mefty分型Ⅲ型ACM的临床资料。15例术中在硬膜外磨除前床突,6例未磨除前... 目的探讨硬膜外前床突旁磨除在Al-Mefty分型Ⅲ型前床突脑膜瘤(ACM)翼点入路手术中应用价值。方法回顾性分析2011年12月至2021年3月经翼点入路显微手术治疗21例Al-Mefty分型Ⅲ型ACM的临床资料。15例术中在硬膜外磨除前床突,6例未磨除前床突。结果磨除前床突的15例中,10例(66.7%)肿瘤全切除,3例大部分切除,2例部分切除;12例(80.0%)术后视力改善,3例无明显变化。未磨除前床突的6例中,2例(33.3%)肿瘤全切除,1例大部分切除,3例部分切除;2例(33.3%)术后视力改善,4例无明显变化。磨除前床突病人肿瘤全切除率和术后视力改善率较未磨除前床突病人明显提高(P<0.05)。术后新发暂时性动眼神经麻痹1例、癫痫发作1例、脑脊液漏1例。21例术后随访6~97个月,平均(37.4±13.8)个月;2例肿瘤部分切除病人出现肿瘤进展;随访期间无死亡病例。结论Al-Mefty分型Ⅲ型ACM与颈内动脉及其分支、视神经、海绵窦等重要神经血管结构的解剖关系紧密,手术难度大。术中硬膜外磨除前床突可增加手术空间,早期控制视神经和ICA,有助于提高肿瘤全切除率和视神经改善率。 展开更多
关键词 前床突脑膜瘤 Al-Mefty分型 翼点入路 显微手术 硬膜外前床突旁磨除 疗效
下载PDF
Serum hyaluronic acid, procollagen type Ⅲ and Ⅳ in histological diagnosis of liver fibrosis 被引量:11
15
作者 Shi-Bin Xie Ji-Lu Yao +2 位作者 Rong-Qin Zheng Xiao-Mou Peng Zhi-Liang Gao the Department of Infectious Diseases, Third Affiliated Hospital, Zhongshan University, Guangzhou 510630, China , 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2003年第1期69-72,共4页
OBJECTIVE: To assess the significance of serum hyaluronic acid (HA), proeollagen type Ⅲ (PCⅢ), collagen type Ⅳ (CⅣ) in the histological diagnosis of liver fibrosis. METHODS: The concentrations of serum HA, PCⅢ, C... OBJECTIVE: To assess the significance of serum hyaluronic acid (HA), proeollagen type Ⅲ (PCⅢ), collagen type Ⅳ (CⅣ) in the histological diagnosis of liver fibrosis. METHODS: The concentrations of serum HA, PCⅢ, CⅣ in 253 patients with chronic liver diseases were measured by radioimmunoassay. Liver biopsies were performed in all patients at the same time. The liver was pathologically evaluated by a pathologist according to a scoring system. Combined with the results of liver pathological diagnosis, the accuracy of serum HA, PCⅢ, CⅣ in diagnosing patients with hepatic fibrosis (staging≥S_2) or cirrhosis (S_4) was assessed using the receiver operating curve (ROC). RESULTS: The cutoff values of serum HA, PCⅢ and CⅣ for identifying patients with hepatic fibrosis (≥S_2) or cirrhosis (S_4) were determined. The cutoff values of serum HA, PCⅢ and CⅣ for detecting patients with fibrosis (stage≥S_2) were 90μg/L, 90μg/L, 75μg/L, respectively; their sensitivity (Se) was 80.4%, 82%, 63.1%; their specificity (Spe) was 70.2%, 60.8%, 83.8%; their positive predictive values (PPV) were 86.7%, 83.5%, 90.4%; their negative predictive values (NPV) were 59.8%, 58.4%, 48.4%, respectively. The cutoff values for detecting patients with liver cirrhosis were 210μg/L for HA, 96.2% for Se, 85.3% for Spe, 65.4% for PPV, 98.8% for NPV; 150μg/L for PCⅢ, 76.4% for Se, 68.7% for Spe, 40.4% for PPV, 91.3% for NPV; 90μg/L for CⅣ, 80% for Se, 75.8% for Spe, 47.8% for PPV, 93.2% for NPV, respectively. CONCLUSIONS: Serum HA, PCⅢ and CⅣ can be determined for an accurate diagnosis of hepatic fibrosis in various stages. HA is the best for screening liver cirrhosis. 展开更多
关键词 hyaluronic acid procollagen type collagen type hepatic fibrosis DIAGNOSIS liver histology
下载PDF
PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production 被引量:20
16
作者 Dahai Zheng Gang Chen +2 位作者 Beichu Guo Genhong Cheng Hong Tang 《Cell Research》 SCIE CAS CSCD 2008年第11期1105-1113,共9页
Infections by coronaviruses such as severe acute respiratory syndrome (SARS) coronavirus (SCoV) and mouse hepatitis virus A59 (MHV-A59) result in very little type I interferon (IFN) production by host cells, w... Infections by coronaviruses such as severe acute respiratory syndrome (SARS) coronavirus (SCoV) and mouse hepatitis virus A59 (MHV-A59) result in very little type I interferon (IFN) production by host cells, which is potentially responsible for the rapid viral growth and severe immunopathology associated with SARS. However, the molecular mechanisms for the low IFN production in cells infected with coronaviruses remain unclear. Here, we provide evidence that Papain-like protease domain 2 (PLP2), a catalytic domain of the nonstructural protein 3 (nsp3) of MHV-A59, can bind to IRF3, cause its deubiquitination and prevent its nuclear translocation. As a consequence, co-expression of PLP2 strongly inhibits CARDIF-, TBK1- and IRF3-mediated IFNp reporter activities. In addition, we show that wild-type PLP2 but not the mutant PLP2 lacking the deubiquitinase (DUB) activity can reduce IFN induction and promote viral growth in cells infected with VSV. Thus, our study uncovered a viral DUB which coronaviruses may use to escape from the host innate antiviral responses. 展开更多
关键词 MHV-A59 PLP2 DEUBIQUITINATION IRF3 type I interferons
下载PDF
The host type I interferon response to viral and bacterial infections 被引量:12
17
作者 AndreaK.PERRY GangCHEN +2 位作者 DahaiZHENG HongTANG GenhongCHENG 《Cell Research》 SCIE CAS CSCD 2005年第6期407-422,共16页
Type I interferons (IFN) are well studied cytokines with anti-viral and immune-modulating functions. Type I IFNsare produced following viral infections, but until recently, the mechanisms of viral recognition leading ... Type I interferons (IFN) are well studied cytokines with anti-viral and immune-modulating functions. Type I IFNsare produced following viral infections, but until recently, the mechanisms of viral recognition leading to IFN productionwere largely unknown. Toll like receptors (TLRs) have emerged as key transducers of type I IFN during viral infectionsby recognizing various viral components. Furthermore, much progress has been made in defining the signaling path-ways downstream of TLRs for type I IFN production. TLR7 and TLR9 have become apparent as universally importantin inducing type I IFN during infection with most viruses, particularly by plasmacytoid dendritic cells. New intracellularviral pattern recognition receptors leading to type I IFN production have been identified. Many bacteria can also inducethe up-regulation of these cytokines. Interestingly, recent studies have found a detrimental effect on host cells if type IIFN is produced during infection with the intracellular gram-positive bacterial pathogen, Listeria monocytogenes. Thisreview will discuss the recent advances made in defining the signaling pathways leading to type I IFN production. 展开更多
关键词 type I interferons Toll-like receptors pattern-recognition receptors virus infections Listeria monocytogenes signaling mechanisms.
下载PDF
IRF family proteins and type I interferon induction in dendritic cells 被引量:9
18
作者 Prafullakumar Tailor Tomohiko Tamura Keiko Ozato 《Cell Research》 SCIE CAS CSCD 2006年第2期134-140,共7页
Dendritic cells (DC), although a minor population in hematopoietic cells, produce type I interferons (IFN) and other cytokines and are essential for innate immunity. They are also potent antigen presenters and reg... Dendritic cells (DC), although a minor population in hematopoietic cells, produce type I interferons (IFN) and other cytokines and are essential for innate immunity. They are also potent antigen presenters and regulate adaptive immunity. Among DC subtypes plasmacytoid DC (pDC) produce the highest amounts of type I IFN. In addition, pro- and anti-inflammatory cytokines such as IL-12 and IL-10 are induced in DC in response to Toll like receptor (TLR) signaling and upon viral infection. Proteins in the IRF family control many aspects of DC activity. IRF-8 and IRF-4 are essential for DC development. They differentially control the development of four DC subsets. IRF-8^-/- mice are largely devoid of pDC and CD8α^+ DC, while IRF-4^-/- mice lack CD4^+ DC. IRF-8^-/-, IRF4^-/-, double knock-out mice have only few CD8α CD4^-DC that lack MHC Ⅱ. IRF proteins also control type Ⅰ IFN induction in DC. IRF-7, activated upon TLR signaling is required for IFN induction not only in pDC, but also in conventional DC (cDC) and non-DC cell types. IRF-3, although contributes to IFN induction in fibroblasts, is dispensable in IFN induction in DC. Our recent evidence reveals that type Ⅰ IFN induction in DC is critically dependent on IRF-8, which acts in the feedback phase of IFN gene induction in DC. Type Ⅰ IFN induction in pDC is mediated by MyD88 dependent signaling pathway, and differs from pathways employed in other cells, which mostly rely on TLR3 and RIG-Ⅰ family proteins. Other pro-inflammatory cytokines are produced in an IRF-5 dependent manner. However, IRF-5 is not required for IFN induction, suggesting the presence of separate mechanisms for induction of type Ⅰ IFN and other pro-inflammatory cytokines. IFN and other cytokines produced by activated DC in turn advance DC maturation and change the phenotype and function of DC. These processes are also likely to be governed by IRF family proteins. 展开更多
关键词 dendritic cells IRF-3 4 5 7 8 type interferon induction activate transcription signaling pathway dependence
下载PDF
An enriched environment increases the expression of fibronectin type Ⅲ domain-containing protein 5 and brain-derived neurotrophic factor in the cerebral cortex of the ischemic mouse brain 被引量:12
19
作者 Ke-Wei Yu Chuan-Jie Wang +7 位作者 Yi Wu Yu-Yang Wang Nian-Hong Wang Shen-Yi Kuang Gang Liu Hong-Yu Xie Cong-Yu Jiang Jun-Fa Wu 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第9期1671-1677,共7页
Many studies have shown that fibronectin type III domain-containing protein 5(FDNC5) and brain-derived neurotrophic factor(BDNF) play vital roles in plasticity after brain injury. An enriched environment refers to an ... Many studies have shown that fibronectin type III domain-containing protein 5(FDNC5) and brain-derived neurotrophic factor(BDNF) play vital roles in plasticity after brain injury. An enriched environment refers to an environment that provides animals with multi-sensory stimulation and movement opportunities. An enriched environment has been shown to promote the regeneration of nerve cells, synapses, and blood vessels in the animal brain after cerebral ischemia;however, the exact mechanisms have not been clarified. This study aimed to determine whether an enriched environment could improve neurobehavioral functions after the experimental inducement of cerebral ischemia and whether neurobehavioral outcomes were associated with the expression of FDNC5 and BDNF. This study established ischemic mouse models using permanent middle cerebral artery occlusion(pMCAO) on the left side. On postoperative day 1, the mice were randomly assigned to either enriched environment or standard housing condition groups. Mice in the standard housing condition group were housed and fed under standard conditions. Mice in the enriched environment group were housed in a large cage, containing various toys, and fed with a standard diet. Sham-operated mice received the same procedure, but without artery occlusion, and were housed and fed under standard conditions. On postoperative days 7 and 14, a beam-walking test was used to assess coordination, balance, and spatial learning. On postoperative days 16–20, a Morris water maze test was used to assess spatial learning and memory. On postoperative day 15, the expression levels of FDNC5 and BDNF proteins in the ipsilateral cerebral cortex were analyzed by western blot assay. The results showed that compared with the standard housing condition group, the motor balance and coordination functions(based on beam-walking test scores 7 and 14 days after operation), spatial learning abilities(based on the spatial learning scores from the Morris water maze test 16–19 days after operation), and memory abilities(based on the memory scores of the Morris water maze test 20 days after operation) of the enriched environment group improved significantly. In addition, the expression levels of FDNC5 and BDNF proteins in the ipsilateral cerebral cortex increased in the enriched environment group compared with those in the standard housing condition group. Furthermore, the Pearson correlation coefficient showed that neurobehavioral functions were positively associated with the expression levels of FDNC5 and BDNF(r = 0.587 and r = 0.840, respectively). These findings suggest that an enriched environment upregulates FDNC5 protein expression in the ipsilateral cerebral cortex after cerebral ischemia, which then activates BDNF protein expression, improving neurological function. BDNF protein expression was positively correlated with improved neurological function. The experimental protocols were approved by the Institutional Animal Care and Use Committee of Fudan University, China(approval Nos. 20160858 A232, 20160860 A234) on February 24, 2016. 展开更多
关键词 beam-walking test brain-derived neurotrophic factor cerebral ischemia correlation analysis enriched environment fibronectin typedomain-containing protein 5 Morris water maze task neural plasticity NEUROPROTECTION permanent middle cerebral artery occlusion
下载PDF
Macroscopic appearance of TypeⅣand giant Type Ⅲ is a high risk for a poor prognosis in pathological stage Ⅱ/Ⅲ advanced gastric cancer with postoperative adjuvant chemotherapy 被引量:2
20
作者 Keishi Yamashita Akira Ema +4 位作者 Kei Hosoda Hiroaki Mieno Hiromitsu Moriya Natsuya Katada Masahiko Watanabe 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2017年第4期166-175,共10页
AIM To evaluate whether a high risk macroscopic appearance(Type Ⅳ and giant Type Ⅲ) is associated with a dismal prognosis after curative surgery, because its prognostic relevance remains elusive in pathological sta... AIM To evaluate whether a high risk macroscopic appearance(Type Ⅳ and giant Type Ⅲ) is associated with a dismal prognosis after curative surgery, because its prognostic relevance remains elusive in pathological stage Ⅱ/Ⅲ(p Stage Ⅱ/Ⅲ) gastric cancer.METHODS One hundred and seventy-two advanced gastric cancer(defined as pT2 or beyond) patients with p Stage Ⅱ/Ⅲ who underwent curative surgery plus adjuvant S1 chemotherapy were evaluated, and the prognostic relevance of a high-risk macroscopic appearance was examined. RESULTS Advanced gastric cancers with a high-risk macroscopic appearance were retrospectively identified by preoperative recorded images. A high-risk macroscopic appearance showed a significantly worse relapse free survival(RFS)(35.7%) and overall survival(OS)(34%) than an average risk appearance(P = 0.0003 and P < 0.0001, respectively). A high-risk macroscopic appearance was significantly associated with the 13^(th) Japanese Gastric Cancer Association(JGCA) pT(P = 0.01), but not with the 13^(th) JGCA pN. On univariate analysis for RFS and OS, prognostic factors included 13^(th) JGCA p Stage(P < 0.0001)and other clinicopathological factors including macroscopic appearance. A multivariate Cox proportional hazards model for univariate prognostic factors identified highrisk macroscopic appearance(P = 0.036, HR = 2.29 for RFS and P = 0.021, HR = 2.74 for OS) as an independent prognostic indicator. CONCLUSION A high-risk macroscopic appearance was associated with a poor prognosis, and it could be a prognostic factor independent of 13^(th) JGCA stage in p Stage Ⅱ/Ⅲ advanced gastric cancer. 展开更多
关键词 Macroscopic feature Gastric cancer type Giant type Stage Ⅱ/
下载PDF
上一页 1 2 112 下一页 到第
使用帮助 返回顶部